Dimitrios Katsarelias

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 28, 2021
Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases.

Martijn S Bethlehem, Dimitrios Katsarelias, Roger Olofsson Bagge

|Jan 05, 2021
Reply to Comment on Katsarelias, D., et al. "The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study." Cancers 2020, 12, 3228.

Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver

|Nov 30, 2020
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial.

Carl Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen

|Nov 05, 2020
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study.

Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver

|Aug 28, 2019
Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trial.

Anna Corderfeldt, Susanne Nielsen, Dimitrios Katsarelias

|Apr 17, 2019
BRAF status as a predictive factor for response in isolated limb perfusion.

Valerio Belgrano, Jan Mattsson, Jonas Nilsson

Pageof 2

Frequent Collaborators

7 joint publications

Roger Olofsson Bagge

3 joint publications

Jonas Nilsson

3 joint publications

Lars Ny

2 joint publications

Rasmus Mikiver